Besides, immune response, early phases of haematopoietic differentiation, rheumatoid diseases—systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), loss of antioxidant potential—also lead to the increased expression of CD38 [2,14,20,33]. The gene discussed is CD38; the disease is rheumatoid arthritis.